EurekAlert! -
14 Jun 2021 06:00
(Arizona State University) Diego Mastroeni of the NDRC teamed up Forest White and Douglas Lauffenburger, to explore how protein and signaling pathways change in patients with Alzheimer's disease. Their work creates a new model of disease progression, taking advantage of the heterogeneity that is inherent to human studies.
Share this Article